MMIT, founded in 1994, stands as a pioneering force in the Health Care and Information Technology sectors. With its headquarters in the United States, it has established itself as a trusted partner in pharmaceutical market access, leveraging nearly two decades of specialized experience. The company's slogan, "Pharmaceutical market access data, analytics, and insights", underscores its dedication to unraveling complex drug coverage issues, thereby facilitating improved access to lifesaving treatments.
MMIT enriches its offerings through notable divisions such as AIS Health and Zitter Health Insights, among others, each providing specialized solutions ranging from healthcare publications to oncology consultancy. Its commitment to innovation is backed by substantial private equity investment from Welsh, Carson, Anderson & Stowe, Ardan Equity, and HgCapital Trust plc, secured in its last funding round on 20 September 2021.